Literature DB >> 3761106

Estimated and measured energy content of infant formulas.

M De Curtis, J Senterre, J Rigo.   

Abstract

This study was undertaken to assess to what extent estimated energy content of 13 infant formulas was related to gross energy measured by bomb calorimetry. Measured gross energy exceeded significantly metabolizable energy as claimed by the manufacturers by applying the classical Atwater's factors by about 12% (range, 6-17%). Measured gross energy also exceeded significantly gross energy calculated by applying either FAO/WHO or our own values of heat combustion of nutrient by 6% (range, 3-9%) and 3.5% (range, 1-6%), respectively. It is concluded that for reasons of symmetry and simplicity, the labeling of the energy content of infant formulas should continue to be calculated by applying the classical Atwater's factors to the nutrient composition. However, when accurate energy balance studies are carried out, the energy content of the diet should be measured by bomb calorimetry rather than be estimated by applying conversion factors to claimed or determined nutrient composition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3761106     DOI: 10.1097/00005176-198609000-00014

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  3 in total

1.  Monitoring steatorrhoea in cystic fibrosis.

Authors:  M De Curtis; F Santamaria; P Ercolini; G Sica; V Bianco; F Ciccimarra
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

2.  Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.

Authors:  K H Hsieh; M F Shaio; T N Liao
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

3.  Effect of taurine supplementation on fat and energy absorption in cystic fibrosis.

Authors:  M De Curtis; F Santamaria; P Ercolini; L Vittoria; G De Ritis; V Garofalo; F Ciccimarra
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.